Inizia
ReutersReuters

FibroGen Announces Positive Type C Meeting With The FDA For Roxadustat In Patients With Anemia Associated With Lower-Risk Myelodysplastic Syndromes

RefinitivMeno di 1 minuto di lettura
FGEN

FibroGen Inc FGEN:

  • FIBROGEN ANNOUNCES POSITIVE TYPE C MEETING WITH THE FDA FOR ROXADUSTAT IN PATIENTS WITH ANEMIA ASSOCIATED WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES

Azioni USAReuters
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Accedi o crea un account gratuito per leggere queste notizie

Altre notizie da Reuters